[Treatment of experimental infections due to gram negative bacteria by means of intravenous streptomycin]
- PMID: 13646816
[Treatment of experimental infections due to gram negative bacteria by means of intravenous streptomycin]
Similar articles
-
Zoonotic bacterial populations, gut fermentation characteristics and methane production in feedlot steers during oral nitroethane treatment and after the feeding of an experimental chlorate product.Anaerobe. 2007 Feb;13(1):21-31. doi: 10.1016/j.anaerobe.2006.11.002. Epub 2007 Jan 5. Anaerobe. 2007. PMID: 17208022
-
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i29-40. doi: 10.1093/jac/dkn249. J Antimicrob Chemother. 2008. PMID: 18684704 Clinical Trial.
-
Evaluation of a model for Escherichia coli O157:H7 colonization in streptomycin-treated adult cattle.Am J Vet Res. 2006 Nov;67(11):1914-20. doi: 10.2460/ajvr.67.11.1914. Am J Vet Res. 2006. PMID: 17078755
-
Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.J Antimicrob Chemother. 2007 May;59(5):926-33. doi: 10.1093/jac/dkm073. Epub 2007 Mar 29. J Antimicrob Chemother. 2007. PMID: 17395686
-
Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.J Infect. 2008 Mar;56(3):185-90. doi: 10.1016/j.jinf.2008.01.003. Epub 2008 Feb 15. J Infect. 2008. PMID: 18280570